Tekturna for hypertension

Share this content:

The FDA has approved Tekturna (aliskiren tablets, from Novartis), a once-daily oral medication for the treatment of hypertension as monotherapy or in combination with other antihypertensive agents. In clinical trials, this direct renin inhibitor demonstrated significant blood pressure reductions for a full 24 hours. Tekturna is expected to be available in March 2007 as 150mg and 300mg tablets.

For more information call (888) TEKTURNA or visit www.tekturna.com.

Loading links....

2017 Upcoming Meetings

Sign Up for Free e-newsletters